Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Perkovic, Vlado; Jardine, Meg J; Neal, Bruce; Bompoint, Severine; Heerspink, Hiddo J L; Charytan, David M; Edwards, Robert; Agarwal, Rajiv; Bakris, George; Bull, Scott; Cannon, Christopher P; Capuano, George; Chu, Pei-Ling; de Zeeuw, Dick; Greene, Tom; Levin, Adeera; Pollock, Carol; Wheeler, David C; Yavin, Yshai; Zhang, Hong; Zinman, Bernard; Meininger, Gary; Brenner, Barry M; Mahaffey, Kenneth W.
N Engl J Med; 380(24): 2295-2306, 2019 06 13.
Artigo em Inglês | MEDLINE | ID: mdl-30990260